Efficacy Observation of Liver Cancer at the Later Stage for the Elderly Treated with Integration of Norcantharidin and Chinese Medicine

CHU Yu-ping,SHEN Lin,BAI Yu
DOI: https://doi.org/10.3969/j.issn.1673-6613.2012.09.012
2012-01-01
Abstract:Objective To observe the clinical efficacy of the integration of norcantharidin and Chinese medicine in the treatment of liver cancer at the later stage for the elderly.Methods 79 cases of the elderly with liver cancer at the later stage were randomized into a treatment group(40 cases)and a control group(39 cases).In the treatment group,the patients were treated with Chinese herbal decoction and norcantharidin.In the control group,the patients were simply treated with chemotherapy,intervention or support therapy.In both groups,the treatment of 28 days made 1 period.The cases were qualified in the research by receiving at least two-period treatment.The median survival time,tumor objective remission rate and the score of Kamofsky performance status(KPS)were observed and compared for the patients between two groups.Results The median survival time was 16 months in the treatment group and was 11 months in the control group,indicating the statistical significant difference in comparison(P0.01).The comparison of the tumor objective remission rate between two groups presented the statistical significant difference(P0.01).The comparison of KPS score between two groups presented the statistical significant difference(P0.05).The incidence rate of adverse reaction for the patients in the treatment group was obviously lower than that in the control group(P0.05).Conclusion The integrated Chinese and western medicine prolongs the median survival time and improves the quality of life for the elderly with liver cancer at the later stage.
What problem does this paper attempt to address?